Utility of In Situ Sodium Alginate/Karaya Gum Gels to Facilitate Gastric Retention in Rodents

September 15, 2012

 

Foster, K.M., M. Morgen, B. Murri, I. Yates, R.M. Fancher, J. Ehrmann, O. Gudmundsson, M.J. Hageman, “Utility of In Situ Sodium Alginate/Karaya Gum Gels to Facilitate Gastric Retention in Rodents,” Int. J. Pharm., 434(2012)406-412.

 

Target validation or demonstration of efficacy requires adequate in vivo exposure of tool molecules to determine their activity in order to validate the model or show the potential usefulness of the pharmacophore. Early discovery work is often carried out with compounds which possess undesirable PK properties in small rodents where the discovery formulation scientist is often forced to dose 2–4 times per day. Gastric retentive formulations in small rodents (rats/mice) could enable increased duration of exposure for compounds with narrow absorption windows or increased residence time for compounds with targets located in the GI tract. The aim of this work is to establish an easily administered gastric retentive gel for rodents in situ using a mixture of sodium alginate and karaya gum. Feasibility studies were conducted in Sprague-Dawley rats using barium sulfate as a radio-opaque tracer. The results show that gastric retention of barium was achieved for rats dosed with the gel formulation relative to a barium suspension. The gastric residence time of the gel varied from 1 h to >8 h (n = 3). The data suggest that sodium alginate/karaya gum gels may be a useful tool to achieve gastric retention in rodent studies.

 

 

 

Topics: 
Bioavailability Enhancement